Dr. Mark Holterman is a pediatric surgeon and a full professor at the University of Illinois College of Medicine. He is committed to advancement in medicine and the search for a cure for chronic illnesses like diabetes. Dr. Mark Holterman is a member of several professional bodies like the American College of Surgeons and the American Academy of Pediatrics. He specializes in research with a keen interest in regenerative medicine, stem cell therapies, novel cancer treatments, and obesity.


As a practicing pediatric surgeon, Dr. Mark Holterman seeks out ways of using fetal stem cells in the treatment of acute diseases. He is a board member of TargaCell, Inc., a biotech organization based in Chicago which has developed an organ-specific system for the delivery of adult stem cells. The company’s state of the art technology involving catheter-based delivery yields a significant improvement in stem cells retention which in turn boosts organ repair activities.


Based in Peoria, Illinois, Dr. Mark Holterman practices pediatric surgery at the Advocate Christ Children’s Hospital and the Children’s Hospital of Illinois, St. Francis Medical Center. He was a co-surgeon at OSF Saint Francis Medical Center where a nine-hour operation saw the first ever trachea transplant on a child completed. The operation was performed on a two-year-old Korean toddler born without a developed trachea. In addition to the medical staff extensive expertise, the operation heavily relied on an engineered stem cell-based organ and a cell incubation processing system (http://markjholterman.strikingly.com/).


Due to his contributions in the field of medicine, Dr. Mark Holterman has earned several awards. He received the Innovative Research Award from the American Diabetes Association, an organization dedicated to funding research in diabetes preventive measures and cures (Doctors.HealthGrove). Dr. Mark Holterman holds a Bachelor of Arts degree in biology from Yale University and a Ph.D. in medicine and immunology from the University of Virginia.